Technical Analysis for ASNS - Arsanis, Inc.

Grade Last Price % Change Price Change
grade F 1.55 -4.91% -0.08
ASNS closed down 4.91 percent on Monday, October 15, 2018, on approximately normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical ASNS trend table...

Date Alert Name Type % Chg
Oct 15 New 52 Week Low Weakness 0.00%
Oct 15 Down 3 Days in a Row Weakness 0.00%
Oct 15 Down 4 Days in a Row Weakness 0.00%
Oct 15 Down 5 Days in a Row Weakness 0.00%
Oct 15 Oversold Stochastic Weakness 0.00%
Oct 12 20 DMA Resistance Bearish -4.91%
Oct 12 Calm After Storm Range Contraction -4.91%
Oct 12 Narrow Range Bar Range Contraction -4.91%
Oct 12 NR7 Range Contraction -4.91%
Oct 12 Stochastic Reached Oversold Weakness -4.91%

Older signals for ASNS ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Arsanis, Inc. is a United States-based company engaged in the discovery and development of monoclonal antibodies (mAbs) for the targeted immunotherapy of serious infections. The Company's mAbs focus on specific pathogens and pathogenic processes. Its product pipeline includes ASN100, ASN200, ASN300, ASN400 and ASN500. Its lead program, ASN100, is being studied to prevent hospital-acquired Staphylococcus aureus pneumonia in mechanically ventilated patients heavily colonized with Staphylococcus aureus in their respiratory tracts. Its ASN200 addresses the unmet medical need caused by drug-resistant extra-intestinal escherichia coli infections. Its ASN300 addresses the unmet medical need due to carbapenem-resistant klebsiella pneumoniae infections. Its ASN400 addresses the unmet medical need due to streptococcus pneumoniae, a leading cause of mortality among the elderly. The ASN500 program consisting of potent mAbs targeting respiratory syncytial virus (RSV), is in the discovery phase.
Is ASNS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 3 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 28.69
52 Week Low 1.46
Average Volume 289,059
200-Day Moving Average 11.6469
50-Day Moving Average 1.8607
20-Day Moving Average 1.713
10-Day Moving Average 1.744
Average True Range 0.2343
ADX 28.2
+DI 28.0221
-DI 20.6153
Chandelier Exit (Long, 3 ATRs ) 2.0371
Chandelier Exit (Short, 3 ATRs ) 2.1629
Upper Bollinger Band 1.9684
Lower Bollinger Band 1.4576
Percent B (%b) 0.18
BandWidth 29.819031
MACD Line -0.1019
MACD Signal Line -0.1249
MACD Histogram 0.023
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.79
Resistance 3 (R3) 1.79 1.70 1.75
Resistance 2 (R2) 1.70 1.64 1.71 1.74
Resistance 1 (R1) 1.63 1.60 1.59 1.63 1.72
Pivot Point 1.54 1.54 1.52 1.55 1.54
Support 1 (S1) 1.47 1.48 1.43 1.47 1.38
Support 2 (S2) 1.38 1.44 1.39 1.36
Support 3 (S3) 1.31 1.38 1.35
Support 4 (S4) 1.31